D-0147-2021 Class III Terminated
FDA drug recall D-0147-2021 was initiated by SCA Pharmaceuticals on Nov 20, 2020 and is designated Class III. Reason for recall: Subpotency: Out-of-specification stability test result for low potency was obtained. The recall status is terminated (terminated Jun 24, 2021). Affected quantity: 4,843 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 23, 2020
- Initiation Date
- Nov 20, 2020
- Termination Date
- Jun 24, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,843 syringes
Product description
Fentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205
Reason for recall
Subpotency: Out-of-specification stability test result for low potency was obtained.
Distribution pattern
Product was distributed to three hospitals in MO & LA.
Code information
Lot #: 1220021578, Exp 12/2/2020; 1220021732, Exp 12/9/2020; 1220022385, Exp 12/29/2020; 1220022582, Exp 1/6/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0147-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026